584,818 Oscar Health, Inc. $OSCR Shares Bought by Halter Ferguson Financial Inc.

Key Points

• Halter Ferguson Financial increased its Oscar Health stake by 93.3%, purchasing 584,818 shares in the third quarter to hold 1.21 million shares worth approximately $37.4 million. Institutional investors and hedge funds collectively own 75.7% of the company.
• Analysts have mixed views, with Oscar Health holding an average “Hold” rating and a consensus price target of $34.90. Recent targets range from $27 to $49, including upgrades from Barclays and Piper Sandler.
• Oscar Health reported strong quarterly results, posting $1.10 in EPS versus the $0.40 consensus estimate and $4.88 billion in revenue, up 70.4% year over year. Shares opened at $33.48, near their 52-week high of $35.01.

Halter Ferguson Financial Inc. grew its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 93.3% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,211,825 shares of the company's stock after buying an additional 584,818 shares during the period. Oscar Health accounts for 6.5% of Halter Ferguson Financial Inc.'s investment portfolio, making the stock its 7th biggest position. Halter Ferguson Financial Inc. owned approximately 0.39% of Oscar Health worth $37,373,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. Assenagon Asset Management S.A. boosted its stake in shares of Oscar Health by 107.5% during the third quarter. Assenagon Asset Management S.A. now owns 2,589,708 shares of the company's stock valued at $79,867,000 after acquiring an additional 1,341,716 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Oscar Health by 22.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 4,192,777 shares of the company's stock valued at $48,078,000 after purchasing an additional 759,837 shares during the last quarter. Wedge Capital Management L L P NC purchased a new position in Oscar Health in the 2nd quarter valued at about $32,855,000. Bank of America Corp DE lifted its holdings in Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company's stock valued at $32,808,000 after purchasing an additional 1,922,732 shares in the last quarter. Finally, Wellington Management Group LLP lifted its holdings in Oscar Health by 65.6% in the 2nd quarter. Wellington Management Group LLP now owns 603,675 shares of the company's stock valued at $17,217,000 after purchasing an additional 239,109 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CAO Victoria Baltrus sold 958 shares of the stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total transaction of $30,129.10. Following the transaction, the chief accounting officer directly owned 213,631 shares in the company, valued at $6,718,694.95. This represents a 0.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 31,422 shares of the stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $988,221.90. Following the transaction, the director owned 449,444 shares in the company, valued at approximately $14,135,013.80. The trade was a 6.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 874,451 shares of company stock worth $26,761,671 over the last ninety days. Insiders own 22.64% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Barclays raised their price target on shares of Oscar Health from $39.00 to $49.00 and gave the stock an "overweight" rating in a research note on Thursday, September 17th. Bank of America boosted their price objective on shares of Oscar Health from $28.00 to $30.00 and gave the company an "underperform" rating in a research report on Thursday, September 17th. Stephens reissued an "equal weight" rating and issued a $34.00 price objective on shares of Oscar Health in a research report on Thursday, September 17th. Wells Fargo & Company upped their price objective on shares of Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research note on Thursday, August 13th. Finally, Piper Sandler restated an "overweight" rating and set a $48.00 target price on shares of Oscar Health in a research report on Thursday, September 17th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Oscar Health presently has an average rating of "Hold" and an average target price of $34.90.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $33.48 on Thursday. The company has a market cap of $10.33 billion, a P/E ratio of 23.91, a P/E/G ratio of 0.37 and a beta of 2.47. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $35.01. The business has a fifty day simple moving average of $31.76 and a 200-day simple moving average of $27.17.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $1.10 EPS for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%. The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. During the same period in the prior year, the firm posted ($0.89) earnings per share. The business's quarterly revenue was up 70.4% compared to the same quarter last year. Equities research analysts forecast that Oscar Health, Inc. will post 1.83 EPS for the current year.

Oscar Health Profile

Oscar Health, Inc is a technology-focused health insurance company that provides health plans and related services in the United States. The company primarily serves individuals and families purchasing coverage through the Affordable Care Act's health insurance marketplace, as well as small businesses and their employees.

Oscar combines health insurance products with digital tools designed to help members manage their care. Its services include online enrollment, virtual care, provider search and appointment support, care navigation, claims and benefits information, and member engagement through web and mobile applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.